放大内镜对结直肠侧向发育型肿瘤非颗粒型的诊断价值
本研究回顾性分析282例结直肠侧向发育型肿瘤非颗粒型(LST-NG)病变,包括250例平坦隆起型(FE)和32例假凹陷型(PD),评估放大内镜(JNET分类和pit pattern分类)与病理及内镜可切除性的关系。PD病变的高级别上皮内瘤变或更严重、黏膜下浸润癌及T1b癌比例显著高于FE病变(均P < .0001)。结论认为放大内镜对LST-NG治疗决策价值有限,尤其对PD病变,强调只要技术可行应行整块内镜切除。
要点
- PD病变的高级别上皮内瘤变或更严重、黏膜下浸润癌及T1b癌比例显著高于FE病变。
- FE病变中无T1b癌,但JNET 2A和2B病变中分别有37.0%和54.8%存在高级别上皮内瘤变或黏膜下浸润<1000μm癌。
- 所有PD病变除1例外均显示均匀JNET 2B,且3例T1b癌均呈多灶黏膜下浸润(≤2000μm)并整块切除。
核心结论
- 放大内镜对LST-NG的治疗决策价值有限,尤其对PD病变,应尽可能行整块内镜切除。
主要发现
- PD病变的高级别上皮内瘤变或更严重、黏膜下浸润癌及T1b癌比例分别为78.1%、34.4%、9.4%,显著高于FE病变的31.2%、2.0%、0%(均P < .0001)。
- FE病变中无T1b癌,但JNET 2A和2B病变中分别有37.0%和54.8%存在高级别上皮内瘤变或黏膜下浸润<1000μm癌。
- 所有PD病变除1例外均显示均匀JNET 2B;3例PD T1b癌呈现不同pit pattern,均有多灶黏膜下浸润(≤2000μm)并整块切除。
关键数值与推荐
- PD病变高级别上皮内瘤变或更严重率78.1% vs FE 31.2%(P < .0001)。
- PD病变黏膜下浸润癌率34.4% vs FE 2.0%(P < .0001)。
- PD病变T1b癌率9.4% vs FE 0%(P < .0001)。
- FE病变中JNET 2A和2B病变的高级上皮内瘤变或黏膜下浸润<1000μm癌率分别为37.0%和54.8%。
临床怎么用
- 对LST-NG病变,尤其PD病变,不应仅依赖放大内镜表现决定治疗方式。
- 只要技术可行,应优先考虑整块内镜切除。
局限性
- 回顾性研究设计。
- PD病变样本量较小(32例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Although magnifying endoscopy is useful for histologic prediction and treatment decision-making in colorectal neoplasia, its clinical significance in laterally spreading tumor nongranular type (LST-NG) remains unclear. We aimed to clarify whether magnifying endoscopy provides clinically meaningful information for therapeutic decision-making, particularly when selecting endoscopic or surgical resection for LST-NG. METHODS: We retrospectively reviewed 282 consecutive LST-NG lesions, including 250 flat-elevated (FE) and 32 pseudodepressed (PD) lesions that underwent magnifying endoscopy and subsequent resection between December 2019 and December 2024. Magnifying narrow-band imaging findings were assessed using the Japan Narrow-band Imaging Expert Team (JNET) classification, and chromoendoscopy findings were assessed using the pit pattern classification; both were compared with histopathologic findings, and endoscopic resectability was evaluated. RESULTS: PD lesions exhibited significantly higher rates of high-grade dysplasia (HGD) or worse (78.1% vs 31.2%), submucosal (SM)-invasive carcinoma (34.4% vs 2.0%), and SM invasion ≥1000 μm (T1b) carcinoma (9.4% vs 0%) than FE lesions (all P < .0001). Among the FE lesions, no T1b carcinoma was observed; however, HGD or SM invasion <1000 μm carcinoma was identified in 37.0% of the JNET type 2A lesions and 54.8% of the JNET type 2B lesions. All but 1 PD lesion showed homogeneous JNET type 2B findings. The 3 PD T1b carcinomas exhibited different pit patterns; all showed multifocal submucosal invasion (≤2000 μm) and were resected en bloc. CONCLUSIONS: Magnifying endoscopy has limited utility in therapeutic decision-making for LST-NG, particularly for PD lesions, indicating the importance of en bloc endoscopic resection whenever technically feasible, regardless of magnifying endoscopic findings.
引用
- Amioka Y, Tanaka H, Yamane M, et al. Diagnostic value of magnifying endoscopy for colorectal laterally spreading tumor nongranular type. Gastrointest Endosc. 2026. PMID: 41580046. doi:10.1016/j.gie.2026.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。